MeSH term
Frequency | Condition_Probility | Adult | 3 | 0.0 |
Comparative Study | 3 | 0.0 |
Humans | 28 | 0.0 |
Animals | 13 | 0.0 |
Blotting, Western | 4 | 0.0 |
Cell Line | 12 | 0.0 |
Collagen/pharmacology | 2 | 1.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Female | 3 | 0.0 |
Ligands | 4 | 0.0 |
Mice | 9 | 0.0 |
Molecular Weight | 2 | 0.0 |
Phosphorylation | 12 | 0.0 |
Precipitin Tests | 2 | 0.0 |
*Receptor Protein-Tyrosine Kinases | 8 | 14.0 |
Receptors, Mitogen/chemistry/genetics/*metabolism | 2 | 100.0 |
Research Support, Non-U.S. Gov't | 16 | 0.0 |
3T3 Cells | 3 | 0.0 |
Cell Adhesion/physiology | 2 | 0.0 |
Collagen/metabolism | 3 | 1.0 |
Rats | 4 | 0.0 |
Receptors, Mitogen/*metabolism | 2 | 12.0 |
Signal Transduction | 5 | 0.0 |
Tumor Cells, Cultured | 7 | 0.0 |
Blotting, Northern | 3 | 0.0 |
Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology | 2 | 0.0 |
Amino Acid Sequence | 4 | 0.0 |
Binding Sites | 3 | 0.0 |
Collagen/*metabolism | 4 | 2.0 |
Molecular Sequence Data | 4 | 0.0 |
Point Mutation | 2 | 0.0 |
Protein Binding | 4 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Tyrosine/metabolism | 2 | 0.0 |
Cell Adhesion | 3 | 0.0 |
Cytoskeletal Proteins/metabolism | 2 | 0.0 |
*Genes, Tumor Suppressor | 3 | 0.0 |
Integrins/metabolism | 2 | 1.0 |
Kinetics | 2 | 0.0 |
*Nuclear Proteins | 3 | 0.0 |
Cell Line, Transformed | 3 | 0.0 |
Cells, Cultured | 6 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Cell Movement | 2 | 0.0 |
Male | 3 | 0.0 |
Mice, Knockout | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Receptor Protein-Tyrosine Kinases/deficiency/genetics/*metabolism | 2 | 66.0 |
Receptors, Mitogen/deficiency/genetics/*metabolism | 2 | 100.0 |
Child, Preschool | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 4 | 0.0 |
*Adaptor Proteins, Signal Transducing | 4 | 0.0 |
*Adaptor Proteins, Vesicular Transport | 2 | 0.0 |
Adolescent | 2 | 0.0 |
Middle Aged | 2 | 0.0 |
RNA, Messenger/metabolism | 4 | 0.0 |
Receptors, Mitogen/genetics/*metabolism | 2 | 100.0 |
Cell Line, Tumor | 3 | 0.0 |
Cell Membrane/metabolism | 2 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Time Factors | 3 | 0.0 |
Up-Regulation | 2 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Protein-Tyrosine Kinase/metabolism | 3 | 0.0 |
Receptors, Mitogen/*chemistry/metabolism | 2 | 66.0 |
Drug Combinations | 2 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Binding Sites/genetics | 2 | 0.0 |
Enzyme Activation | 2 | 0.0 |
Cell Differentiation/immunology | 2 | 0.0 |
TNF Receptor-Associated Factor 6 | 2 | 1.0 |
Tetradecanoylphorbol Acetate/pharmacology | 2 | 0.0 |
p38 Mitogen-Activated Protein Kinases | 3 | 0.0 |
Receptor Protein-Tyrosine Kinases/*metabolism | 3 | 1.0 |
Hela Cells | 2 | 0.0 |
